Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic

Jan Baan1, Ze Yie Yong, Karel T Koch

  • 1Department of Cardiology and Cardio-thoracic Surgery, Academic Medical Center-University of Amsterdam, Amsterdam, The Netherlands. j.baan@amc.nl

American Heart Journal
|March 10, 2010
PubMed

Insights

Percutaneous aortic valve implantation (PAVI) with the CoreValve prosthesis leads to a high rate of atrioventricular block requiring permanent pacemaker implantation (PPI) and new left bundle-branch block (LBBB). Factors like narrow outflow tracts and mitral calcification predict PPI need.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Cardiac conduction disorders and permanent pacemaker implantation (PPI) are common after surgical aortic valve replacement.
  • Percutaneous aortic valve implantation (PAVI) is an alternative procedure with its own risk profile.
  • Understanding conduction disturbances post-PAVI is crucial for patient management.

Purpose of the Study:

  • To determine the incidence of cardiac conduction disorders after PAVI using the CoreValve prosthesis.
  • To identify clinical factors associated with the development of these conduction disorders.
  • To evaluate the need for PPI and new-onset left bundle-branch block (LBBB) post-PAVI.

Main Methods:

  • A study of 34 patients undergoing PAVI with the CoreValve bioprosthesis.
  • Pre- and postprocedural electrocardiographic (ECG) evaluation at 1-week and 1-month follow-up.
  • Analysis of clinical variables including medical history, echocardiography, and angiography.

Main Results:

  • Seven patients (20.6%) required PPI, all developing total atrioventricular block within 3 days.
  • Factors associated with PPI included smaller left ventricular outflow tract diameter, more left-sided heart axis, severe mitral annular calcification, and smaller postimplantation indexed effective orifice area.
  • The incidence of new LBBB was 65%, associated with deeper prosthesis implantation.

Conclusions:

  • PAVI with the CoreValve prosthesis is associated with a high incidence of total atrioventricular block requiring PPI and new-onset LBBB.
  • Preexisting conduction disturbance, narrow left ventricular outflow tract, and mitral annular calcification predict the need for PPI.
  • Prosthesis implantation depth is the sole predictor for new-onset LBBB.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Heart Valves01:16

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...